These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20045645)

  • 1. Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.
    Brotherton-Pleiss CE; Dillon MP; Ford AP; Gever JR; Carter DS; Gleason SK; Lin CJ; Moore AG; Thompson AW; Villa M; Zhai Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1031-6. PubMed ID: 20045645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and synthesis of a novel and selective drug-like P2X(1) antagonist.
    Jaime-Figueroa S; Greenhouse R; Padilla F; Dillon MP; Gever JR; Ford AP
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3292-5. PubMed ID: 15927468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor.
    Chambers LJ; Stevens AJ; Moses AP; Michel AD; Walter DS; Davies DJ; Livermore DG; Fonfria E; Demont EH; Vimal M; Theobald PJ; Beswick PJ; Gleave RJ; Roman SA; Senger S
    Bioorg Med Chem Lett; 2010 May; 20(10):3161-4. PubMed ID: 20399651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Jahangir A; Alam M; Carter DS; Dillon MP; Bois DJ; Ford AP; Gever JR; Lin C; Wagner PJ; Zhai Y; Zira J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1632-5. PubMed ID: 19231178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists.
    Gleave RJ; Walter DS; Beswick PJ; Fonfria E; Michel AD; Roman SA; Tang SP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4951-4. PubMed ID: 20634071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist.
    Chen X; Pierce B; Naing W; Grapperhaus ML; Phillion DP
    Bioorg Med Chem Lett; 2010 May; 20(10):3107-11. PubMed ID: 20392639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
    Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.
    Perez-Medrano A; Donnelly-Roberts DL; Honore P; Hsieh GC; Namovic MT; Peddi S; Shuai Q; Wang Y; Faltynek CR; Jarvis MF; Carroll WA
    J Med Chem; 2009 May; 52(10):3366-76. PubMed ID: 19397270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor.
    Hoveyda HR; Roy MO; Blanc S; Noël S; Salvino JM; Ator MA; Fraser G
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1991-6. PubMed ID: 21376585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.
    Jamieson C; Basten S; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Moir EM; Morrow JA; Papakosta M; Rankovic Z; Smith L
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5753-6. PubMed ID: 20805031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
    Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors.
    Virginio C; Robertson G; Surprenant A; North RA
    Mol Pharmacol; 1998 Jun; 53(6):969-73. PubMed ID: 9614197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
    Chen HJ; Liu Y; Wang LN; Shen Q; Li J; Nan FJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2876-9. PubMed ID: 20363629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.
    Duplantier AJ; Dombroski MA; Subramanyam C; Beaulieu AM; Chang SP; Gabel CA; Jordan C; Kalgutkar AS; Kraus KG; Labasi JM; Mussari C; Perregaux DG; Shepard R; Taylor TJ; Trevena KA; Whitney-Pickett C; Yoon K
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3708-11. PubMed ID: 21565499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors.
    Furber M; Alcaraz L; Bent JE; Beyerbach A; Bowers K; Braddock M; Caffrey MV; Cladingboel D; Collington J; Donald DK; Fagura M; Ince F; Kinchin EC; Laurent C; Lawson M; Luker TJ; Mortimore MM; Pimm AD; Riley RJ; Roberts N; Robertson M; Theaker J; Thorne PV; Weaver R; Webborn P; Willis P
    J Med Chem; 2007 Nov; 50(24):5882-5. PubMed ID: 17963373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
    Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
    J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel quinolinone adenosine A2B antagonists.
    McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.
    Wang Y; Duraiswami C; Madauss KP; Tran TB; Williams SP; Deng SJ; Graybill TL; Hammond M; Jones DG; Grygielko ET; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4916-9. PubMed ID: 19664922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.